Ruth Oratz, MD

Articles by Ruth Oratz, MD

Dr. Oratz on PARP Inhibitors to Treat Patients With Breast Cancer

May 14th 2019

Cancer Network spoke with Ruth Oratz, MD, a medical oncologist at NYU Langone Perlmutter Cancer Center in New York City, about the use of PARP inhibitors for breast cancer.

Latest Updated Articles

Dr. Oratz on PARP Inhibitors to Treat Patients With Breast Cancer
May 14th 2019

Trending on CancerNetwork

FDA Approves Ruxolitinib Tablets for Hematologic Malignancies

FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC

Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer

Precision Medicine and the “Slow Death” of Transplant in Lymphoma

135 Elacestrant in Combination With Everolimus or Abemaciclib in Patients With ER+/HER2– Locally Advanced or Metastatic Breast Cancer (mBC): Phase 2 Results From ELEVATE, an Open-Label, Umbrella Study